Symposia & Webinars
Diagnostic and therapeutic considerations to tailor treatments based on underlying ischemic mechanisms
The starting point for the analysis of treatments for CCS patients is the updated version of the ESC Guidelines, in particular the change from disease to “syndrome” referring to coronary heart syndrome. Moreover, obstructive CAD has been overestimated as the cause of ischemia.
In this scenario, Prof. Luis H Gowdak speaks about: